Literature DB >> 21451580

Protein transduction by pseudotyped lentivirus-like nanoparticles.

T Aoki1, K Miyauchi, E Urano, R Ichikawa, J Komano.   

Abstract

A simple, efficient and reproducible method to transduce proteins into mammalian cells has not been established. Here we describe a novel protein transduction method based on a lentiviral vector. We have developed a method to package several thousand foreign protein molecules into a lentivirus-like nanoparticle (LENA) and deliver them into mammalian cells. In this proof-of-concept study, we used β-lactamase (BlaM) as a reporter molecule. The amino-terminus of BlaM was fused to the myristoylation signal of lyn, which was placed upstream of the amino-terminus of Gag (BlaM-gag-pol). By co-transfection of plasmids encoding BlaM-gag-pol and vesicular stomatitis virus-G (VSV-G) into 293T cells, LENA were produced containing BlaM enzyme molecules as many as Gag per capsid, which has been reported to be ∼5000 molecules, but lacking the viral genome. Infection of 293T and MT-4 cells by VSV-G-pseudotyped BlaM-containing LENA led to successful transduction of BlaM molecules into the cell cytoplasm, as detected by cleavage of the fluorescent BlaM substrate CCF2-AM. LENA-mediated transient protein transduction does not damage cellular DNA, and the preparation of highly purified protein is not necessary. This technology is potentially useful in various basic and clinical applications.

Entities:  

Mesh:

Year:  2011        PMID: 21451580     DOI: 10.1038/gt.2011.38

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  12 in total

1.  Virus-Like Particles Derived from HIV-1 for Delivery of Nuclear Proteins: Improvement of Production and Activity by Protein Engineering.

Authors:  Marc-André Robert; Viktoria Lytvyn; Francis Deforet; Rénald Gilbert; Bruno Gaillet
Journal:  Mol Biotechnol       Date:  2017-01       Impact factor: 2.695

Review 2.  Aptamers as Modular Components of Therapeutic Nucleic Acid Nanotechnology.

Authors:  Martin Panigaj; M Brittany Johnson; Weina Ke; Jessica McMillan; Ekaterina A Goncharova; Morgan Chandler; Kirill A Afonin
Journal:  ACS Nano       Date:  2019-11-05       Impact factor: 15.881

3.  Therapeutic potential of HIV protease-activable CASP3.

Authors:  Kosuke Miyauchi; Emiko Urano; Mari Takizawa; Reiko Ichikawa; Jun Komano
Journal:  Sci Rep       Date:  2012-04-11       Impact factor: 4.379

4.  A VSV-based assay quantifies coronavirus Mpro/3CLpro/Nsp5 main protease activity and chemical inhibition.

Authors:  Francesco Costacurta; Stephan Geley; Seyad Arad Mogadashi; Andre Volland; Emmanuel Heilmann; Bernhard Rupp; Reuben Stewart Harris; Dorothee von Laer
Journal:  Commun Biol       Date:  2022-04-27

5.  Targeted genome editing by lentiviral protein transduction of zinc-finger and TAL-effector nucleases.

Authors:  Yujia Cai; Rasmus O Bak; Jacob Giehm Mikkelsen
Journal:  Elife       Date:  2014-04-24       Impact factor: 8.140

6.  Targeted delivery of CRISPR-Cas9 and transgenes enables complex immune cell engineering.

Authors:  Jennifer R Hamilton; Connor A Tsuchida; David N Nguyen; Brian R Shy; E Riley McGarrigle; Cindy R Sandoval Espinoza; Daniel Carr; Franziska Blaeschke; Alexander Marson; Jennifer A Doudna
Journal:  Cell Rep       Date:  2021-06-01       Impact factor: 9.423

7.  DNA transposition by protein transduction of the piggyBac transposase from lentiviral Gag precursors.

Authors:  Yujia Cai; Rasmus O Bak; Louise Bechmann Krogh; Nicklas H Staunstrup; Brian Moldt; Thomas J Corydon; Lisbeth Dahl Schrøder; Jacob Giehm Mikkelsen
Journal:  Nucleic Acids Res       Date:  2013-11-21       Impact factor: 16.971

8.  Driving DNA transposition by lentiviral protein transduction.

Authors:  Yujia Cai; Jacob Giehm Mikkelsen
Journal:  Mob Genet Elements       Date:  2014-06-23

Review 9.  Intracellular targeting with engineered proteins.

Authors:  Shane Miersch; Sachdev S Sidhu
Journal:  F1000Res       Date:  2016-08-10

Review 10.  Recent Advances in CRISPR/Cas9 Delivery Strategies.

Authors:  Bon Ham Yip
Journal:  Biomolecules       Date:  2020-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.